ChulaCov19 mRNA vaccine

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameChulaCov19 mRNA vaccine
Drug Alias NameComvigen VaccineBivalent ChulaCov19 BNA159.2ChulaCov19 BNA159 vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulantsAnti-Coronavirus spike glycoprotein
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChulalongkorn University
China Registration ClassN/A

Develop Information

Active CompaniesBionet-Asia Co LtdChulalongkorn UniversityTechnovalia Pty Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A